Cargando…

Relationship of ethnicity and CD4 Count with glucose metabolism among HIV patients on Highly-Active Antiretroviral Therapy (HAART)

BACKGROUND: HIV patients on HAART are prone to metabolic abnormalities, including insulin resistance, lipodystrophy and diabetes. This study purports to investigate the relationship of ethnicity and CD4+ T cell count attained after stable highly-active antiretroviral treatment (HAART) with glucose m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Misra, Ranjita, Chandra, Prakash, Riechman, Steven E, Long, Dustin M, Shinde, Shivani, Pownall, Henry J, Coraza, Ivonne, Lewis, Dorothy E, Sekhar, Rajagopal V, Balasubramanyam, Ashok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751670/ https://www.ncbi.nlm.nih.gov/pubmed/23607267 http://dx.doi.org/10.1186/1472-6823-13-13

Ejemplares similares

Effectiveness of a Group-Based Culturally Tailored Lifestyle Intervention Program on Changes in Risk Factors for Type 2 Diabetes among Asian Indians in the United States
por: Patel, Rupal M., et al.
Publicado: (2017)

Tolerability of antiretroviral therapy (HAART) in elderly age
por: Celesia, B M
Publicado: (2010)

Islet-Specific T-Cell Responses and Proinflammatory Monocytes Define Subtypes of Autoantibody-Negative Ketosis-Prone Diabetes
por: Brooks-Worrell, Barbara M., et al.
Publicado: (2013)

HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact
por: Lichtenstein, Kenneth, et al.
Publicado: (2007)

HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanisms
por: Lichtenstein, Kenneth, et al.
Publicado: (2007)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
por: Sinha, Rajesh, et al.
Publicado: (2008)

Race/ethnicity and HAART initiation in a military HIV infected cohort
por: Johnson, Erica N, et al.
Publicado: (2014)

The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience
por: Erhabor, Osaro, et al.
Publicado: (2009)

Craniofacial morphology of HIV-infected adolescents undergoing highly active antiretroviral therapy (HAART): An original research
por: Neeraja, M., et al.
Publicado: (2020)

Trend of CD4+ Cell Counts at Diagnosis and Initiation of Highly Active Antiretroviral Therapy (HAART): Korea HIV/AIDS Cohort Study, 1992-2015
por: Kim, Min Jung, et al.
Publicado: (2017)

Pathogenesis of A(−)β(+) Ketosis-Prone Diabetes
por: Patel, Sanjeet G., et al.
Publicado: (2013)

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
por: Bourry, Olivier, et al.
Publicado: (2009)

Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients
por: Low, Yee Shan, et al.
Publicado: (2018)

The Potential of Spirulina platensis to Ameliorate the Adverse Effects of Highly Active Antiretroviral Therapy (HAART)
por: Sibiya, Thabani, et al.
Publicado: (2022)

A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

Nephrotoxicity of HAART
por: Kalyesubula, Robert, et al.
Publicado: (2011)

Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)
por: Bisicchia, F, et al.
Publicado: (2010)

Hypertension among HIV-Infected Adults Receiving Highly Active Antiretroviral Therapy (HAART) in Malaysia
por: Hejazi, Nazisa, et al.
Publicado: (2014)

Prevalence of Depressive Symptoms Amongst Highly Active Antiretroviral Therapy (HAART) Patients in AIDSRelief Uganda
por: Shumba, Constance, et al.
Publicado: (2013)

Short and Long-Term Incidence of Tuberculosis and CD4-Cell Count Dynamic on HAART in Senegal
por: Etard, Jean-François, et al.
Publicado: (2009)

Response to HAART according to sex and origin (immigrant vs autochthonous) in a cohort of patients who initiate antiretroviral treatment
por: Perez-Molina, JA, et al.
Publicado: (2010)

Emergency of Primary NNRTI Resistance Mutations without Antiretroviral Selective Pressure in a HAART-Treated Child
por: Machado, Elizabeth S., et al.
Publicado: (2009)

Interventions to promote adherence to Antiretroviral Therapy (HAART) among adult patients at an HIV/AIDS program in Uganda
por: Muhumuza, Simon, et al.
Publicado: (2010)

Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda
por: Alibhai, Arif, et al.
Publicado: (2010)

The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria
por: Taiwo, Olaniyi O, et al.
Publicado: (2010)

Neurobehavioral Effects in HIV-Positive Individuals Receiving Highly Active Antiretroviral Therapy (HAART) in Gaborone, Botswana
por: Lawler, Kathy, et al.
Publicado: (2011)

Chest X-ray findings in HIV- infected Highly Active Antiretroviral Treatment (HAART)-naïve patients
por: Akinbami, Akinsegun, et al.
Publicado: (2012)

Neurodegeneration in the HAART era
por: Brew, Bruce J
Publicado: (2010)

Glutathione Synthesis Is Diminished in Patients With Uncontrolled Diabetes and Restored by Dietary Supplementation With Cysteine and Glycine
por: Sekhar, Rajagopal V., et al.
Publicado: (2011)

Isolation, identification, and carriage of candidal species in PHLAs and their correlation with immunological status in cases with and without HAART
por: Kantheti, Lalith Prakash Chandra, et al.
Publicado: (2012)

Absolute lymphocyte count as a surrogate marker for CD4 counts after six months of HAART initiation in a resource-limited setting in India
por: Srirangaraj, S., et al.
Publicado: (2012)

Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review
por: Muula, Adamson S, et al.
Publicado: (2007)

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)
por: Dold, Leona, et al.
Publicado: (2015)

A Case of Ocular Kaposi’s Sarcoma Successfully Treated with Highly Active Antiretroviral Therapy (HAART) Combined with Docetaxel
por: Jin, Chongfei, et al.
Publicado: (2018)

Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial
por: Amogne, Wondwossen, et al.
Publicado: (2015)

Race/Ethnicity, Lipoproteins, and Antiretroviral Therapy
Publicado: (2006)

HIV and HAART-Associated Dyslipidemia
por: Feeney, Eoin R, et al.
Publicado: (2011)

HAART and the liver: friend or foe?
por: Pineda, JA, et al.
Publicado: (2010)

HAART, THE HEART AND THE POTENTIAL FOR INTERACTION
por: Coyle, Liam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jar17ko7omm822osp9lph14h4k